---
title: "GLP-1 Drugs May Influence Financial Decision-Making"
url: https://newscentral.site/glp-1-drugs-may-influence-financial-decision-making/
language: en
publisher: "News Central Site"
section: "Business"
published: 2026-10-08T15:13:54.000Z
updated: 2026-10-11T11:42:16.934Z
id: 4bd20b26-2831-4c18-b9c3-93887836cb08
source: "CBS MoneyWatch https://www.cbsnews.com/news/glp-1-drugs-wharton-study-impulsive-spending/"
attribution: "Link to https://newscentral.site/glp-1-drugs-may-influence-financial-decision-making/ and name News Central Site when you quote or summarize this story."
---

# GLP-1 Drugs May Influence Financial Decision-Making

Researchers at the Wharton School of the University of Pennsylvania are investigating whether GLP-1 medications can minimize impulsive decisions and reduce addictive behaviors.

A growing body of research indicates that drugs targeting the GLP-1 receptor can have a broader impact than just helping people lose weight by reducing addictive behaviors.

Experts at the Wharton School of the University of Pennsylvania are now exploring whether these medications could also benefit individuals' financial health by minimizing impulsive decisions, such as excessive spending or compulsive shopping.

The researchers will investigate how GLP-1s affect the body's reward system, a complex network of brain structures that reinforces certain behaviors, to determine if the drugs can suppress temptations like luxury purchases, gambling or other hard-to-control activities.

Researchers believe that GLP-1 drugs can influence a person's decision-making process by affecting the brain's reward system, which is responsible for consumption choices.

The team plans to recruit approximately 180 participants for the study, set to take place at the University of Pennsylvania's MindCORE research lab from mid-October through March 2027.

Researchers will gather baseline information about participants by asking basic questions about their demographic background, mental health, and use of GLP-1 medications, if applicable. Participants will also be asked to complete a short cognitive exercise as part of this initial assessment.

The research subjects will then undergo magnetic resonance imaging while performing four tasks designed to test how the brain responds to different stimuli. These tasks include two focused on food and two related to financial decisions, which will help researchers understand how the brain's reward system processes value, reward, and decision-making.

During one of these financial tasks, participants will be shown a series of 14 images depicting various products, services, experiences, and spending opportunities, including the Powerball jackpot. This "passive viewing" technique allows researchers to monitor people's spontaneous brain responses without asking them to take any action or make decisions.

In the second phase of the research, participants will be required to make a financial decision, which they will then indicate by pressing a button on the MRI machine's control panel.

This action is meant to test their genuine preferences and ensure that their decisions are not influenced by external factors. After completing the decision-making process within the MRI facility, participants will need to follow through on one of their chosen actions outside of the study environment. The goal is to assess the long-term implications of GLP-1 medication in real-world scenarios.

---
Source: [CBS MoneyWatch](https://www.cbsnews.com/news/glp-1-drugs-wharton-study-impulsive-spending/)  
Published by News Central Site: https://newscentral.site/glp-1-drugs-may-influence-financial-decision-making/